Literature DB >> 10881208

Addiction and schizophrenia.

P Batel1.   

Abstract

Epidemiologic studies in the general population and those based on the clinical assessment of schizophrenic populations have revealed a high degree of overlap between schizophrenia and addictive disorders. The abuse of psychoactive substances (including alcohol) throughout life is so frequent (50%) that the possibility of a specific link inevitably arises. Various hypotheses have been suggested to explain the high co-morbidity between schizophrenia and addiction: 1) The social-environmental hypothesis has been developed but studies have provided poor evidence to validate it. 2) The possible shared biological vulnerability between schizophrenia and addictions led researchers to explore common genetic determinants and study the involvement of the dopaminergic and opioid systems in the aetiology of both schizophrenia and the abuse of and dependence on psychoactive drugs. 3) Finally, the theory of self-medication suggests that schizophrenics may be attempting to counter the deficit linked to their disorders by using the substances they take or their dependency-type behaviour to cope with their emotional problems. The clinical profile of schizophrenic addicts does seem to display some distinctive features, such as the high level of depressive co-morbidity, very high nicotine and alcohol dependence, with a very poor prognosis. These patients are difficult to manage; the possibility of pharmacologic interactions between the substances they are taking and neuroleptic medication calls for prudence, and their compliance is also poor. Addictive disorders in schizophrenics are currently a topic of active research intended to lead to identifying specific treatments. The early identification of addictive disorders in schizophrenics should make it possible to limit their development and improve the prognosis.

Entities:  

Mesh:

Year:  2000        PMID: 10881208     DOI: 10.1016/s0924-9338(00)00203-0

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  29 in total

Review 1.  Cannabis and psychosis.

Authors:  Louisa Degenhardt; Wayne Hall
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

Review 2.  Microarray technology and its application on nicotine research.

Authors:  Ming D Li; Ozien Konu; Justin K Kane; Kevin G Becker
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

3.  Picturing neuroscience research through a human rights lens: imaging first-episode schizophrenic treatment-naive individuals.

Authors:  Marleen Eijkholt; James A Anderson; Judy Illes
Journal:  Int J Law Psychiatry       Date:  2012-02-02

Review 4.  Negative affective states and cognitive impairments in nicotine dependence.

Authors:  F Scott Hall; Andre Der-Avakian; Thomas J Gould; Athina Markou; Mohammed Shoaib; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-06-06       Impact factor: 8.989

Review 5.  Regulation of feeding-associated peptides and receptors by nicotine.

Authors:  M D Li; S L Parker; J K Kane
Journal:  Mol Neurobiol       Date:  2000 Aug-Dec       Impact factor: 5.590

Review 6.  Optogenetic investigation of neural circuits underlying brain disease in animal models.

Authors:  Kay M Tye; Karl Deisseroth
Journal:  Nat Rev Neurosci       Date:  2012-03-20       Impact factor: 34.870

7.  Nicotine exposure during adolescence: cognitive performance and brain gene expression in adult heterozygous reeler mice.

Authors:  Emilia Romano; Federica De Angelis; Lisa Ulbrich; Antonella De Jaco; Andrea Fuso; Giovanni Laviola
Journal:  Psychopharmacology (Berl)       Date:  2013-12-13       Impact factor: 4.530

8.  Cannabis use and the risk of developing a psychotic disorder.

Authors:  Wayne Hall; Louisa Degenhardt
Journal:  World Psychiatry       Date:  2008       Impact factor: 49.548

9.  Presynaptic type III neuregulin 1 is required for sustained enhancement of hippocampal transmission by nicotine and for axonal targeting of alpha7 nicotinic acetylcholine receptors.

Authors:  Chongbo Zhong; Chuang Du; Melissa Hancock; Marjolijn Mertz; David A Talmage; Lorna W Role
Journal:  J Neurosci       Date:  2008-09-10       Impact factor: 6.167

10.  European network for promoting the physical health of residents in psychiatric and social care facilities (HELPS): background, aims and methods.

Authors:  Prisca Weiser; Thomas Becker; Carolin Losert; Köksal Alptekin; Loretta Berti; Lorenzo Burti; Alexandra Burton; Mojca Dernovsek; Eva Dragomirecka; Marion Freidl; Fabian Friedrich; Aneta Genova; Arunas Germanavicius; Ulaş Halis; John Henderson; Peter Hjorth; Taavi Lai; Jens Ivar Larsen; Katarzyna Lech; Ramona Lucas; Roxana Marginean; David McDaid; Maya Mladenova; Povl Munk-Jørgensen; Alexandru Paziuc; Petronela Paziuc; Stefan Priebe; Katarzyna Prot-Klinger; Johannes Wancata; Reinhold Kilian
Journal:  BMC Public Health       Date:  2009-08-28       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.